A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
Clinical trial NCT01597245 · COMPLETED
Trial details
- NCT number
- NCT01597245
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-18
- Primary completion
- 2014-03-25
- Enrollment
- 1224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.